Advertisement
Screener

Arena Pharmaceuticals, Inc. Comprehensive Income

Arena Pharmaceuticals, Inc. Comprehensive Income

Arena Pharmaceuticals, Inc. reported Comprehensive Income of -$617.41 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-02-23

  • Arena Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-12-31 was -$156.01M.
  • Arena Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$196.28M.
  • Arena Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-06-30 was -$146.21M.
  • Arena Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-03-31 was -$118.91M.
  • Arena Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$617.41M.
  • Arena Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$405.34M, a 201.58% decline from fiscal 2019.
  • Arena Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was $399.01M.
  • Arena Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$29.44M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2021-12-31-$156.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$352.29M
derived: sum of 2 quarters · filed 2022-02-23
-$498.50M
derived: sum of 3 quarters · filed 2022-02-23
-$617.41M
10-K · filed 2022-02-23
2021-09-30-$196.28M
10-Q · filed 2021-11-04
-$342.49M
derived: sum of 2 quarters · filed 2021-11-04
-$461.40M
10-Q · filed 2021-11-04
-$584.41M
derived: sum of 4 quarters · filed 2022-02-23
2021-06-30-$146.21M
10-Q · filed 2021-08-05
-$265.12M
10-Q · filed 2021-08-05
-$388.13M
derived: sum of 3 quarters · filed 2022-02-23
-$486.67M
derived: sum of 4 quarters · filed 2022-02-23
2021-03-31-$118.91M
10-Q · filed 2021-05-05
-$241.93M
derived: sum of 2 quarters · filed 2022-02-23
-$340.46M
derived: sum of 3 quarters · filed 2022-02-23
-$422.87M
derived: sum of 4 quarters · filed 2022-02-23
2020-12-31-$123.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$221.55M
derived: sum of 2 quarters · filed 2022-02-23
-$303.95M
derived: sum of 3 quarters · filed 2022-02-23
-$405.34M
10-K · filed 2022-02-23
2020-09-30-$98.54M
10-Q · filed 2021-11-04
-$180.94M
derived: sum of 2 quarters · filed 2021-11-04
-$282.32M
10-Q · filed 2021-11-04
-$370.77M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30-$82.40M
10-Q · filed 2021-08-05
-$183.79M
10-Q · filed 2021-08-05
-$272.24M
derived: sum of 3 quarters · filed 2022-02-23
-$344.97M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31-$101.39M
10-Q · filed 2021-05-05
-$189.84M
derived: sum of 2 quarters · filed 2022-02-23
-$262.56M
derived: sum of 3 quarters · filed 2022-02-23
-$323.16M
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31-$88.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$161.18M
derived: sum of 2 quarters · filed 2022-02-23
-$221.78M
derived: sum of 3 quarters · filed 2022-02-23
$399.01M
10-K · filed 2022-02-23
2019-09-30-$72.73M
10-Q · filed 2020-11-09
-$133.33M
derived: sum of 2 quarters · filed 2020-11-09
$487.46M
10-Q · filed 2020-11-09
$556.04M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30-$60.60M
10-Q · filed 2020-08-05
$560.19M
10-Q · filed 2020-08-05
$628.77M
derived: sum of 3 quarters · filed 2021-02-23
$594.61M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$620.79M
10-Q · filed 2020-05-07
$689.37M
derived: sum of 2 quarters · filed 2021-02-23
$655.21M
derived: sum of 3 quarters · filed 2021-02-23
$623.44M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31$68.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
$34.42M
derived: sum of 2 quarters · filed 2021-02-23
$2.65M
derived: sum of 3 quarters · filed 2021-02-23
-$29.44M
10-K · filed 2021-02-23
2018-09-30-$34.16M
10-Q · filed 2019-11-08
-$65.93M
derived: sum of 2 quarters · filed 2019-11-08
-$98.02M
10-Q · filed 2019-11-08
-$112.09M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$31.77M
10-Q · filed 2019-08-09
-$63.86M
10-Q · filed 2019-08-09
-$77.93M
derived: sum of 3 quarters · filed 2020-02-27
-$110.73M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$32.09M
10-Q · filed 2019-05-09
-$46.16M
derived: sum of 2 quarters · filed 2020-02-27
-$78.96M
derived: sum of 3 quarters · filed 2020-02-27
-$100.36M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$14.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$46.87M
derived: sum of 2 quarters · filed 2020-02-27
-$68.28M
derived: sum of 3 quarters · filed 2020-02-27
-$89.52M
10-K · filed 2020-02-27
2017-09-30-$32.80M
10-Q · filed 2018-11-08
-$54.20M
derived: sum of 2 quarters · filed 2018-11-08
-$75.45M
10-Q · filed 2018-11-08
-$40.85M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$21.41M
10-Q · filed 2018-08-07
-$42.66M
10-Q · filed 2018-08-07
-$8.05M
derived: sum of 3 quarters · filed 2019-02-28
-$19.71M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$21.25M
10-Q · filed 2018-05-09
$13.36M
derived: sum of 2 quarters · filed 2019-02-28
$1.69M
derived: sum of 3 quarters · filed 2019-02-28
-$26.73M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$34.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$22.94M
derived: sum of 2 quarters · filed 2019-02-28
-$5.48M
derived: sum of 3 quarters · filed 2019-02-28
-$24.44M
10-K · filed 2019-02-28
2016-09-30-$11.66M
10-Q · filed 2017-11-08
-$40.09M
derived: sum of 2 quarters · filed 2017-11-08
-$59.04M
10-Q · filed 2017-11-08
-$91.09M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30-$28.42M
10-Q · filed 2017-08-08
-$47.38M
10-Q · filed 2017-08-08
-$79.43M
derived: sum of 3 quarters · filed 2018-03-14
-$108.72M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31-$18.96M
10-Q · filed 2017-05-09
-$51.00M
derived: sum of 2 quarters · filed 2018-03-14
-$80.30M
derived: sum of 3 quarters · filed 2018-03-14
-$106.58M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31-$32.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$61.35M
derived: sum of 2 quarters · filed 2018-03-14
-$87.63M
derived: sum of 3 quarters · filed 2018-03-14
-$112.07M
10-K · filed 2018-03-14
2015-09-30-$29.30M
10-Q · filed 2016-11-09
-$55.58M
derived: sum of 2 quarters · filed 2016-11-09
-$80.02M
10-Q · filed 2016-11-09
-$112.88M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30-$26.28M
10-Q · filed 2016-08-09
-$50.72M
10-Q · filed 2016-08-09
-$83.58M
derived: sum of 3 quarters · filed 2017-03-15
-$114.19M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31-$24.44M
10-Q · filed 2016-05-09
-$57.30M
derived: sum of 2 quarters · filed 2017-03-15
-$87.91M
derived: sum of 3 quarters · filed 2017-03-15
-$115.84M
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31-$32.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
-$63.47M
derived: sum of 2 quarters · filed 2017-03-15
-$91.40M
derived: sum of 3 quarters · filed 2017-03-15
-$63.33M
10-K · filed 2017-03-15
2014-09-30-$30.61M
10-Q · filed 2015-11-09
-$58.54M
derived: sum of 2 quarters · filed 2015-11-09
-$30.47M
10-Q · filed 2015-11-09
-$53.79M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$27.93M
10-Q · filed 2015-08-07
$145.00K
10-Q · filed 2015-08-07
-$23.18M
derived: sum of 3 quarters · filed 2016-02-29
-$39.08M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$28.07M
10-Q · filed 2015-05-11
$4.75M
derived: sum of 2 quarters · filed 2016-02-29
-$11.15M
derived: sum of 3 quarters · filed 2016-02-29
$29.34M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$23.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$39.22M
derived: sum of 2 quarters · filed 2016-02-29
$1.27M
derived: sum of 3 quarters · filed 2016-02-29
-$19.20M
10-K · filed 2016-02-29
2013-09-30-$15.90M
10-Q · filed 2014-11-06
$24.59M
derived: sum of 2 quarters · filed 2014-11-06
$4.13M
10-Q · filed 2014-11-06
-$16.45M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$40.49M
10-Q · filed 2014-08-06
$20.02M
10-Q · filed 2014-08-06
-$550.00K
derived: sum of 3 quarters · filed 2015-03-02
-$15.48M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31-$20.46M
10-Q · filed 2014-05-12
-$41.04M
derived: sum of 2 quarters · filed 2015-03-02
-$55.97M
derived: sum of 3 quarters · filed 2015-03-02
-$80.31M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$20.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$35.51M
derived: sum of 2 quarters · filed 2015-03-02
-$59.84M
derived: sum of 3 quarters · filed 2015-03-02
-$84.73M
10-K · filed 2015-03-02
2012-09-30-$14.93M
10-Q · filed 2013-11-12
-$39.27M
derived: sum of 2 quarters · filed 2013-11-12
-$64.16M
10-Q · filed 2013-11-12
-$89.61M
derived: sum of 4 quarters · filed 2014-03-03
2012-06-30-$24.33M
10-Q · filed 2013-08-05
-$49.22M
10-Q · filed 2013-08-05
-$74.68M
derived: sum of 3 quarters · filed 2014-03-03
-$100.56M
derived: sum of 4 quarters · filed 2014-03-03
2012-03-31-$24.89M
10-Q · filed 2013-05-09
-$50.34M
derived: sum of 2 quarters · filed 2014-03-03
-$76.23M
derived: sum of 3 quarters · filed 2014-03-03
2011-12-31-$25.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03
-$51.34M
derived: sum of 2 quarters · filed 2014-03-03
-$109.45M
10-K · filed 2014-03-03
2011-09-30-$25.88M
10-Q · filed 2012-11-09
-$83.99M
10-Q · filed 2012-11-09
2010-12-31-$120.51M
10-K · filed 2013-03-01